These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

168 related items for PubMed ID: 3365688

  • 1. Cytotoxic effects of m-[131I]- and m-[125I]iodobenzylguanidine on the human neuroblastoma cell lines SK-N-SH and SK-N-LO.
    Bruchelt G, Girgert R, Buck J, Wolburg H, Niethammer D, Treuner J.
    Cancer Res; 1988 Jun 01; 48(11):2993-7. PubMed ID: 3365688
    [Abstract] [Full Text] [Related]

  • 2. Specific uptake of m-[125I]iodobenzylguanidine in the human neuroblastoma cell line SK-N-SH.
    Buck J, Bruchelt G, Girgert R, Treuner J, Niethammer D.
    Cancer Res; 1985 Dec 01; 45(12 Pt 1):6366-70. PubMed ID: 3864530
    [Abstract] [Full Text] [Related]

  • 3. Therapeutic effect of m-[131I]- and m-[125I]iodobenzylguanidine on neuroblastoma multicellular tumor spheroids of different sizes.
    Weber W, Weber J, Senekowitsch-Schmidtke R.
    Cancer Res; 1996 Dec 01; 56(23):5428-34. PubMed ID: 8968097
    [Abstract] [Full Text] [Related]

  • 4. Active uptake and extravesicular storage of m-iodobenzylguanidine in human neuroblastoma SK-N-SH cells.
    Smets LA, Loesberg C, Janssen M, Metwally EA, Huiskamp R.
    Cancer Res; 1989 Jun 01; 49(11):2941-4. PubMed ID: 2720653
    [Abstract] [Full Text] [Related]

  • 5. Cytotoxicity of alpha-particle-emitting m-[211At]astatobenzylguanidine on human neuroblastoma cells.
    Strickland DK, Vaidyanathan G, Zalutsky MR.
    Cancer Res; 1994 Oct 15; 54(20):5414-9. PubMed ID: 7923174
    [Abstract] [Full Text] [Related]

  • 6. In vitro therapeutic targeting of neuroblastomas using 125I-labelled meta-iodobenzylguanidine.
    Guerreau D, Thedrez P, Fritsch P, Saccavini JC, Metivier H, Nolibe D, Masse R, Coornaert S, Chatal JF.
    Int J Cancer; 1990 Jun 15; 45(6):1164-8. PubMed ID: 2351489
    [Abstract] [Full Text] [Related]

  • 7. Accumulation of m-iodobenzylguanidine by neuroblastoma cells results from independent uptake and storage mechanisms.
    Montaldo PG, Lanciotti M, Casalaro A, Cornaglia-Ferraris P, Ponzoni M.
    Cancer Res; 1991 Aug 15; 51(16):4342-6. PubMed ID: 1868458
    [Abstract] [Full Text] [Related]

  • 8. Biology of metaiodobenzylguanidine interactions with human neuroblastoma cells.
    Iavarone A, Lasorella A, Servidei T, Riccardi R, Troncone L, Mastrangelo R.
    J Nucl Biol Med (1991); 1991 Aug 15; 35(4):186-90. PubMed ID: 1823815
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Hyperbaric oxygen enhances the effects of meta-iodobenzylguanidine (MIBG) on energy metabolism and lipid peroxidation in the human neuroblastoma cell line SK-N-BE(2C).
    Cornelissen J, Van Kuilenburg AB, Elzinga L, Van der Kleij AD, Voûte PA, Van Gennip AH.
    Anticancer Res; 1997 Aug 15; 17(1A):259-64. PubMed ID: 9066662
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. No-carrier-added iodine-131-FIBG: evaluation of an MIBG analog.
    Vaidyanathan G, Zhao XG, Strickland DK, Zalutsky MR.
    J Nucl Med; 1997 Feb 15; 38(2):330-4. PubMed ID: 9025764
    [Abstract] [Full Text] [Related]

  • 15. A 4-methyl-substituted meta-iodobenzylguanidine analogue with prolonged retention in human neuroblastoma cells.
    Vaidyanathan G, Welsh PC, Vitorello KC, Snyder S, Friedman HS, Zalutsky MR.
    Eur J Nucl Med Mol Imaging; 2004 Oct 15; 31(10):1362-70. PubMed ID: 15205923
    [Abstract] [Full Text] [Related]

  • 16. Validation of 4-[fluorine-18]fluoro-3-iodobenzylguanidine as a positron-emitting analog of MIBG.
    Vaidyanathan G, Affleck DJ, Zalutsky MR.
    J Nucl Med; 1995 Apr 15; 36(4):644-50. PubMed ID: 7699460
    [Abstract] [Full Text] [Related]

  • 17. In vitro and in vivo studies with no-carrier added radioiodinated MIBG.
    Franceschini R, Pecorale A, Chinol M, Calcagni ML, Servidei T, Riccardi R, Troncone L.
    Q J Nucl Med; 1995 Dec 15; 39(4 Suppl 1):72-7. PubMed ID: 9002755
    [Abstract] [Full Text] [Related]

  • 18. Pharmacokinetics and intracellular distribution of the tumor-targeted radiopharmaceutical m-iodo-benzylguanidine in SK-N-SH neuroblastoma and PC-12 pheochromocytoma cells.
    Smets LA, Janssen M, Rutgers M, Ritzen K, Buttenhuis C.
    Int J Cancer; 1991 Jun 19; 48(4):609-15. PubMed ID: 2045205
    [Abstract] [Full Text] [Related]

  • 19. Distribution of m-IBG in nude mice bearing LAN-5 neuroblastoma xenografts and in vitro cell culture.
    Van der Wall H, Durbidge M, White L, Taylor D, Murray IP.
    In Vivo; 1991 Jun 19; 5(2):123-6. PubMed ID: 1768781
    [Abstract] [Full Text] [Related]

  • 20. No-carrier-added iodine-131-MIBG: evaluation of a therapeutic preparation.
    Mairs RJ, Cunningham SH, Russell J, Armour A, Owens J, McKellar K, Gaze MN.
    J Nucl Med; 1995 Jun 19; 36(6):1088-95. PubMed ID: 7769433
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.